Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-24

Clinical Trial Update: Montelukast for Treatment of Uremic Pruritus [NA]

View source ↗

Summary

A completed clinical trial evaluated montelukast for treating uremic pruritus in patients with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Montelukast (Montelukast)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: Renal Insufficiency, Chronic | NA | Status: COMPLETED